Adherence to New Oral Anticoagulation Therapy in Turkey

Drug Adherence in Patients Taking New Oral Anticoagulation Therapy in Turkey

This study will compose a national database of drug adherence and investigate the factors that affect drug adherence in patients taking new oral anticoagulation therapy in Turkish Population.

NOACs have several clinical and pharmacological advantages over warfarin however suboptimal adherence is one of the most common causes of failure to respond to medications and outcomes.

This observational multicenter, retrospective study, will compose a national database of drug adherence and investigate the factors that affect drug adherence in patients taking new oral anticoagulation therapy in Turkey.

Social support and adherence to therapy factors that may affect drug adherence and adverse events will be assessed by self-report questionnaires.

Non-adherence will be tested for demographic, clinical, awareness of NOAC therapy and socioeconomic factors.

Inclusion Criteria:

• Patients >18 years old
• Outpatients using a NOAC for at least 3 months duration, with a primary diagnosis of new-onset, non-valvular atrial fibrillation
• Patients signed patient informed sheet and informed consent form

Exclusion Criteria:

• Patients under 18 years old
• Patients refused to sign informed consent form